Aadi Bioscience, Inc
Aadi is a commercial-stage biopharmaceutical company focused on precision therapies for genetically-defined cancers.
69 employees · est. 2011 · Los Angeles, United States
Kura Oncology, Inc.
Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer lives.
315 employees · est. 2014 · San Diego, United States
Aadi Bioscience, Inc is the older company (2011 vs 2014); Kura Oncology, Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | Aadi Bioscience, Inc | Kura Oncology, Inc. |
|---|---|---|
| Founded | ||
| Founded | 2011 older | 2014 |
| Headquarters | ||
| Headquarters | Los Angeles, United States | San Diego, United States |
| Employees | ||
| Employees | 69 | 315 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Life Sciences | Biotechnology, Pharmaceutical |
| Funding Stage | ||
| Funding Stage | Post Ipo Equity | Unknown |
| Total Funding | ||
| Total Funding | $250.50M | $1.17B |
| Funding Rounds | ||
| Funding Rounds | 3 | 12 |
| Services | ||
| Services | Not tracked yet | Development of novel cancer therapeutics, Precision medicine research, Investigation of drug combinations |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with cancer, Caregivers, Healthcare providers, Investors |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Precision Therapy, MTOR Inhibition, Genetically-defined Cancers, Nanoparticle Technology, FDA-approved Drug, PEComa, Cancer Therapy, Leadership Team, Precision Medicine, Patient-centric Approach, MTOR Pathway, Oncology, Clinical Development, Precision Oncology | Precision Medicine, Biopharmaceuticals, Oncology, Cancer Therapeutics, Menin Inhibition, Farnesyl Transferase Inhibition, Treatment Resistance, Relapsed Acute Myeloid Leukemia, NPM1 Mutation, Smart Combination Regimens, Compound Development, Pharmaceutical Commercialization, Cancer Biology, Oral Oncology Drugs, Targeted Cancer Therapies |
| Website | ||
| Website | aadibio.com | kuraoncology.com |
About Aadi Bioscience, Inc
Aadi Bioscience, Inc. is a commercial-stage biopharmaceutical company with a focus on precision therapies for genetically-defined cancers. The company leverages precision medicine and nanoparticle technology to maximize the potential of mTOR inhibition, aiming to offer transformative therapies to ca...
About Kura Oncology, Inc.
Kura Oncology, Inc., founded in 2014 and headquartered in the United States, is a leading player in the Biotechnology and Pharmaceutical sectors. The company is committed to its mission: "Our mission is to realize the promise of precision medicines to help patients with cancer lead better, longer li...
We will tell you when either one moves
BounceWatch watches Aadi Bioscience, Inc and Kura Oncology, Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Aadi Bioscience, Inc and Kura Oncology, Inc. — by email.
Frequently Asked Questions
Compare Aadi Bioscience, Inc with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Aadi Bioscience, Inc on 12 Sep 2024, and Kura Oncology, Inc. on 10 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
